换一批
换一批A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.
第一作者：
Balazs,Halmos
第一单位：
University Hospitals, Seidman Cancer Center, Case Western Reserve University, Case Comprehensive Cancer Center, Cleveland, OH, USA, bh2376@columbia.edu.
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);剂量效应关系, 药物(Dose-Response Relationship, Drug);胃肠肿瘤(Gastrointestinal Neoplasms);人类(Humans);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);中年人(Middle Aged);有机铂化合物(Organoplatinum Compounds);哌啶类(Piperidines);蛋白激酶抑制剂(Protein Kinase Inhibitors);喹唑啉类(Quinazolines);受体, 血管内皮生长因子(Receptors, Vascular Endothelial Growth Factor);紫杉烷类(Taxoids)
DOI
10.1007/s10637-013-9945-8
PMID
23553066
发布时间
2022-03-25
- 浏览6
Investigational new drugs
1244-50页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
